富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/29 | 1,694 | 1,762 | 1,691 | 1,754 | +60 | +3.5% | 224,800 |
| 2024/02/28 | 1,715 | 1,737 | 1,674 | 1,694 | -12 | -0.7% | 267,300 |
| 2024/02/27 | 1,699 | 1,714 | 1,689 | 1,706 | -11 | -0.6% | 165,700 |
| 2024/02/26 | 1,727 | 1,739 | 1,687 | 1,717 | -4 | -0.2% | 243,300 |
| 2024/02/22 | 1,727 | 1,731 | 1,700 | 1,721 | -9 | -0.5% | 205,800 |
| 2024/02/21 | 1,775 | 1,789 | 1,728 | 1,730 | -41 | -2.3% | 242,300 |
| 2024/02/20 | 1,809 | 1,835 | 1,754 | 1,771 | -25 | -1.4% | 414,400 |
| 2024/02/19 | 1,719 | 1,798 | 1,711 | 1,796 | +114 | +6.8% | 554,600 |
| 2024/02/16 | 1,622 | 1,708 | 1,607 | 1,682 | +91 | +5.7% | 549,400 |
| 2024/02/15 | 1,660 | 1,679 | 1,581 | 1,591 | -64 | -3.9% | 445,200 |
| 2024/02/14 | 1,691 | 1,700 | 1,612 | 1,655 | -50 | -2.9% | 557,800 |
| 2024/02/13 | 1,716 | 1,757 | 1,680 | 1,705 | +27 | +1.6% | 1,005,400 |
| 2024/02/09 | 1,661 | 1,696 | 1,581 | 1,678 | -303 | -15.3% | 2,218,400 |
| 2024/02/08 | 2,005 | 2,005 | 1,949 | 1,981 | +6 | +0.3% | 254,500 |
| 2024/02/07 | 1,951 | 1,977 | 1,939 | 1,975 | +12 | +0.6% | 110,600 |
| 2024/02/06 | 1,950 | 1,985 | 1,949 | 1,963 | +19 | +1% | 191,900 |
| 2024/02/05 | 2,037 | 2,037 | 1,934 | 1,944 | -76 | -3.8% | 244,700 |
| 2024/02/02 | 1,995 | 2,022 | 1,988 | 2,020 | +34 | +1.7% | 188,900 |
| 2024/02/01 | 1,970 | 1,996 | 1,960 | 1,986 | +15 | +0.8% | 144,700 |
| 2024/01/31 | 1,954 | 1,971 | 1,932 | 1,971 | +11 | +0.6% | 107,500 |
| 2024/01/30 | 1,976 | 2,000 | 1,954 | 1,960 | -2 | -0.1% | 171,700 |
| 2024/01/29 | 1,938 | 1,964 | 1,934 | 1,962 | +40 | +2.1% | 88,600 |
| 2024/01/26 | 1,933 | 1,948 | 1,917 | 1,922 | -1 | -0.1% | 120,600 |
| 2024/01/25 | 1,944 | 1,945 | 1,896 | 1,923 | -37 | -1.9% | 239,400 |
| 2024/01/24 | 1,958 | 1,992 | 1,943 | 1,960 | +23 | +1.2% | 185,700 |
| 2024/01/23 | 1,914 | 1,952 | 1,912 | 1,937 | +25 | +1.3% | 139,800 |
| 2024/01/22 | 1,912 | 1,930 | 1,890 | 1,912 | -19 | -1% | 175,500 |
| 2024/01/19 | 1,974 | 1,978 | 1,907 | 1,931 | -18 | -0.9% | 190,900 |
| 2024/01/18 | 1,989 | 1,993 | 1,932 | 1,949 | -41 | -2.1% | 218,400 |
| 2024/01/17 | 2,010 | 2,060 | 1,973 | 1,990 | -17 | -0.8% | 276,500 |
| 2024/01/16 | 1,998 | 2,059 | 1,998 | 2,007 | +17 | +0.9% | 343,500 |
| 2024/01/15 | 1,916 | 1,993 | 1,908 | 1,990 | +75 | +3.9% | 227,000 |
| 2024/01/12 | 1,957 | 1,957 | 1,894 | 1,915 | +12 | +0.6% | 173,600 |
| 2024/01/11 | 1,919 | 1,936 | 1,893 | 1,903 | +15 | +0.8% | 168,300 |
| 2024/01/10 | 1,884 | 1,902 | 1,861 | 1,888 | +2 | +0.1% | 165,900 |
| 2024/01/09 | 1,883 | 1,916 | 1,864 | 1,886 | +43 | +2.3% | 272,900 |
| 2024/01/05 | 1,848 | 1,858 | 1,832 | 1,843 | +31 | +1.7% | 196,700 |
| 2024/01/04 | 1,770 | 1,815 | 1,756 | 1,812 | +73 | +4.2% | 171,300 |
| 2023/12/29 | 1,750 | 1,766 | 1,730 | 1,739 | -18 | -1% | 128,600 |
| 2023/12/28 | 1,748 | 1,763 | 1,730 | 1,757 | +19 | +1.1% | 181,100 |
| 2023/12/27 | 1,685 | 1,760 | 1,673 | 1,738 | +73 | +4.4% | 258,300 |
| 2023/12/26 | 1,640 | 1,666 | 1,628 | 1,665 | +55 | +3.4% | 242,800 |
| 2023/12/25 | 1,649 | 1,650 | 1,606 | 1,610 | -20 | -1.2% | 49,000 |
| 2023/12/22 | 1,612 | 1,635 | 1,612 | 1,630 | +27 | +1.7% | 66,300 |
| 2023/12/21 | 1,625 | 1,634 | 1,602 | 1,603 | -33 | -2% | 70,000 |
| 2023/12/20 | 1,651 | 1,656 | 1,630 | 1,636 | -8 | -0.5% | 88,600 |
| 2023/12/19 | 1,650 | 1,664 | 1,629 | 1,644 | -4 | -0.2% | 105,300 |
| 2023/12/18 | 1,600 | 1,654 | 1,590 | 1,648 | +20 | +1.2% | 134,200 |
| 2023/12/15 | 1,661 | 1,667 | 1,625 | 1,628 | -56 | -3.3% | 212,100 |
| 2023/12/14 | 1,714 | 1,744 | 1,678 | 1,684 | -1 | -0.1% | 279,200 |
301～
350
件表示中 / 6958件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 128,500円 | +15.7% | +5.3% | 3.54% | 9.29倍 | 0.69倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 63,900円 | -9.6% | -30.2% | 4.69% | 25.83倍 | 0.48倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,900円 | +150.0% | - | 0.00% | - | 16.18倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 205,700円 | +4.5% | -33.7% | 3.40% | 20.56倍 | 0.59倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 150,100円 | +1.2% | -13.9% | 5.66% | 8.85倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
市場注目の銘柄
チャート関連のコラム
